FDA 483 - McKesson Corporation - July 03, 2018

McKesson Corporation, a wholesale distributor in San Francisco, CA, was cited for deficiencies related to its handling of illegitimate products. The firm's systems were inadequate for identifying, quarantining, and making determinations about suspect or illegitimate products upon receiving notifications. Additionally, procedures for notifying trading partners and retaining sufficient tracing information were found to be deficient.